世界のヒト白血球抗原（HLA）検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Leukocyte Antigen (HLA) Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5200 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User	￥819,000 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ヒト白血球抗原（HLA）検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（分子計測技術、非分子計測技術）、用途別市場規模（病院、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ヒト白血球抗原（HLA）検査の市場動向 ・企業の競争状況、市場シェア ・ヒト白血球抗原（HLA）検査の種類別市場規模と予測2016-2027（分子計測技術、非分子計測技術） ・ヒト白血球抗原（HLA）検査の用途別市場規模と予測2016-2027（病院、研究所、その他） ・ヒト白血球抗原（HLA）検査の北米市場規模2016-2027（アメリカ、カナダ） ・ヒト白血球抗原（HLA）検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト白血球抗原（HLA）検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト白血球抗原（HLA）検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト白血球抗原（HLA）検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、F. Hoffman-La Roche、Bio-Rad Laboratories、QIAGEN N.V.、Illumina、Immucor、CareDx、Becton Dickinson、Hologic、GenDx、Biofortuna） ・結論

A blood test equipment that identifies antigens on the surface of cells and tissues.

Market Analysis and Insights: Global Human Leukocyte Antigen (HLA) Testing Market
The global Human Leukocyte Antigen (HLA) Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Leukocyte Antigen (HLA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Leukocyte Antigen (HLA) Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Leukocyte Antigen (HLA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Leukocyte Antigen (HLA) Testing market.

Global Human Leukocyte Antigen (HLA) Testing Scope and Market Size
Human Leukocyte Antigen (HLA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Leukocyte Antigen (HLA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Assay Technologies
Non-molecular Assay Technologies

Segment by Application
Hospital
Research Institute
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
F. Hoffman-La Roche
Bio-Rad Laboratories
QIAGEN N.V.
Illumina
Immucor
CareDx
Becton Dickinson
Hologic
GenDx
Biofortuna

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Assay Technologies
1.2.3 Non-molecular Assay Technologies
1.3 Market by Application
1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Leukocyte Antigen (HLA) Testing Market Perspective (2016-2027)
2.2 Human Leukocyte Antigen (HLA) Testing Growth Trends by Regions
2.2.1 Human Leukocyte Antigen (HLA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Leukocyte Antigen (HLA) Testing Historic Market Share by Regions (2016-2021)
2.2.3 Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Regions (2022-2027)
2.3 Human Leukocyte Antigen (HLA) Testing Industry Dynamic
2.3.1 Human Leukocyte Antigen (HLA) Testing Market Trends
2.3.2 Human Leukocyte Antigen (HLA) Testing Market Drivers
2.3.3 Human Leukocyte Antigen (HLA) Testing Market Challenges
2.3.4 Human Leukocyte Antigen (HLA) Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Leukocyte Antigen (HLA) Testing Players by Revenue
3.1.1 Global Top Human Leukocyte Antigen (HLA) Testing Players by Revenue (2016-2021)
3.1.2 Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Players (2016-2021)
3.2 Global Human Leukocyte Antigen (HLA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Leukocyte Antigen (HLA) Testing Revenue
3.4 Global Human Leukocyte Antigen (HLA) Testing Market Concentration Ratio
3.4.1 Global Human Leukocyte Antigen (HLA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Leukocyte Antigen (HLA) Testing Revenue in 2020
3.5 Human Leukocyte Antigen (HLA) Testing Key Players Head office and Area Served
3.6 Key Players Human Leukocyte Antigen (HLA) Testing Product Solution and Service
3.7 Date of Enter into Human Leukocyte Antigen (HLA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Leukocyte Antigen (HLA) Testing Breakdown Data by Type
4.1 Global Human Leukocyte Antigen (HLA) Testing Historic Market Size by Type (2016-2021)
4.2 Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Type (2022-2027)

5 Human Leukocyte Antigen (HLA) Testing Breakdown Data by Application
5.1 Global Human Leukocyte Antigen (HLA) Testing Historic Market Size by Application (2016-2021)
5.2 Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Leukocyte Antigen (HLA) Testing Market Size (2016-2027)
6.2 North America Human Leukocyte Antigen (HLA) Testing Market Size by Type
6.2.1 North America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021)
6.2.2 North America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027)
6.2.3 North America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2027)
6.3 North America Human Leukocyte Antigen (HLA) Testing Market Size by Application
6.3.1 North America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021)
6.3.2 North America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027)
6.3.3 North America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2027)
6.4 North America Human Leukocyte Antigen (HLA) Testing Market Size by Country
6.4.1 North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021)
6.4.2 North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Human Leukocyte Antigen (HLA) Testing Market Size (2016-2027)
7.2 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Type
7.2.1 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021)
7.2.2 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027)
7.2.3 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2027)
7.3 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Application
7.3.1 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021)
7.3.2 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027)
7.3.3 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2027)
7.4 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country
7.4.1 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021)
7.4.2 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size (2016-2027)
8.2 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Type
8.2.1 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Application
8.3.1 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region
8.4.1 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Leukocyte Antigen (HLA) Testing Market Size (2016-2027)
9.2 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Type
9.2.1 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021)
9.2.2 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027)
9.2.3 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2027)
9.3 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Application
9.3.1 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021)
9.3.2 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027)
9.3.3 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2027)
9.4 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country
9.4.1 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021)
9.4.2 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size (2016-2027)
10.2 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Type
10.2.1 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Application
10.3.1 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country
10.4.1 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Testing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 F. Hoffman-La Roche
11.2.1 F. Hoffman-La Roche Company Details
11.2.2 F. Hoffman-La Roche Business Overview
11.2.3 F. Hoffman-La Roche Human Leukocyte Antigen (HLA) Testing Introduction
11.2.4 F. Hoffman-La Roche Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.2.5 F. Hoffman-La Roche Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Human Leukocyte Antigen (HLA) Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN N.V.
11.4.1 QIAGEN N.V. Company Details
11.4.2 QIAGEN N.V. Business Overview
11.4.3 QIAGEN N.V. Human Leukocyte Antigen (HLA) Testing Introduction
11.4.4 QIAGEN N.V. Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.4.5 QIAGEN N.V. Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Human Leukocyte Antigen (HLA) Testing Introduction
11.5.4 Illumina Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.5.5 Illumina Recent Development
11.6 Immucor
11.6.1 Immucor Company Details
11.6.2 Immucor Business Overview
11.6.3 Immucor Human Leukocyte Antigen (HLA) Testing Introduction
11.6.4 Immucor Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.6.5 Immucor Recent Development
11.7 CareDx
11.7.1 CareDx Company Details
11.7.2 CareDx Business Overview
11.7.3 CareDx Human Leukocyte Antigen (HLA) Testing Introduction
11.7.4 CareDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.7.5 CareDx Recent Development
11.8 Becton Dickinson
11.8.1 Becton Dickinson Company Details
11.8.2 Becton Dickinson Business Overview
11.8.3 Becton Dickinson Human Leukocyte Antigen (HLA) Testing Introduction
11.8.4 Becton Dickinson Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.8.5 Becton Dickinson Recent Development
11.9 Hologic
11.9.1 Hologic Company Details
11.9.2 Hologic Business Overview
11.9.3 Hologic Human Leukocyte Antigen (HLA) Testing Introduction
11.9.4 Hologic Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.9.5 Hologic Recent Development
11.10 GenDx
11.10.1 GenDx Company Details
11.10.2 GenDx Business Overview
11.10.3 GenDx Human Leukocyte Antigen (HLA) Testing Introduction
11.10.4 GenDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.10.5 GenDx Recent Development
11.11 Biofortuna
11.11.1 Biofortuna Company Details
11.11.2 Biofortuna Business Overview
11.11.3 Biofortuna Human Leukocyte Antigen (HLA) Testing Introduction
11.11.4 Biofortuna Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
11.11.5 Biofortuna Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Molecular Assay Technologies
Table 3. Key Players of Non-molecular Assay Technologies
Table 4. Global Human Leukocyte Antigen (HLA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Human Leukocyte Antigen (HLA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Leukocyte Antigen (HLA) Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Human Leukocyte Antigen (HLA) Testing Market Share by Regions (2016-2021)
Table 8. Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Human Leukocyte Antigen (HLA) Testing Market Share by Regions (2022-2027)
Table 10. Human Leukocyte Antigen (HLA) Testing Market Trends
Table 11. Human Leukocyte Antigen (HLA) Testing Market Drivers
Table 12. Human Leukocyte Antigen (HLA) Testing Market Challenges
Table 13. Human Leukocyte Antigen (HLA) Testing Market Restraints
Table 14. Global Human Leukocyte Antigen (HLA) Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Human Leukocyte Antigen (HLA) Testing Market Share by Players (2016-2021)
Table 16. Global Top Human Leukocyte Antigen (HLA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Leukocyte Antigen (HLA) Testing as of 2020)
Table 17. Ranking of Global Top Human Leukocyte Antigen (HLA) Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Human Leukocyte Antigen (HLA) Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Leukocyte Antigen (HLA) Testing Product Solution and Service
Table 21. Date of Enter into Human Leukocyte Antigen (HLA) Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Human Leukocyte Antigen (HLA) Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Testing Product
Table 64. Thermo Fisher Scientific Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. F. Hoffman-La Roche Company Details
Table 67. F. Hoffman-La Roche Business Overview
Table 68. F. Hoffman-La Roche Human Leukocyte Antigen (HLA) Testing Product
Table 69. F. Hoffman-La Roche Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 70. F. Hoffman-La Roche Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Human Leukocyte Antigen (HLA) Testing Product
Table 74. Bio-Rad Laboratories Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. QIAGEN N.V. Company Details
Table 77. QIAGEN N.V. Business Overview
Table 78. QIAGEN N.V. Human Leukocyte Antigen (HLA) Testing Product
Table 79. QIAGEN N.V. Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 80. QIAGEN N.V. Recent Development
Table 81. Illumina Company Details
Table 82. Illumina Business Overview
Table 83. Illumina Human Leukocyte Antigen (HLA) Testing Product
Table 84. Illumina Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 85. Illumina Recent Development
Table 86. Immucor Company Details
Table 87. Immucor Business Overview
Table 88. Immucor Human Leukocyte Antigen (HLA) Testing Product
Table 89. Immucor Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 90. Immucor Recent Development
Table 91. CareDx Company Details
Table 92. CareDx Business Overview
Table 93. CareDx Human Leukocyte Antigen (HLA) Testing Product
Table 94. CareDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 95. CareDx Recent Development
Table 96. Becton Dickinson Company Details
Table 97. Becton Dickinson Business Overview
Table 98. Becton Dickinson Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 99. Becton Dickinson Recent Development
Table 100. Hologic Company Details
Table 101. Hologic Business Overview
Table 102. Hologic Human Leukocyte Antigen (HLA) Testing Product
Table 103. Hologic Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 104. Hologic Recent Development
Table 105. GenDx Company Details
Table 106. GenDx Business Overview
Table 107. GenDx Human Leukocyte Antigen (HLA) Testing Product
Table 108. GenDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 109. GenDx Recent Development
Table 110. Biofortuna Company Details
Table 111. Biofortuna Business Overview
Table 112. Biofortuna Human Leukocyte Antigen (HLA) Testing Product
Table 113. Biofortuna Revenue in Human Leukocyte Antigen (HLA) Testing Business (2016-2021) & (US$ Million)
Table 114. Biofortuna Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Leukocyte Antigen (HLA) Testing Market Share by Type: 2020 VS 2027
Figure 2. Molecular Assay Technologies Features
Figure 3. Non-molecular Assay Technologies Features
Figure 4. Global Human Leukocyte Antigen (HLA) Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Research Institute Case Studies
Figure 7. Other Case Studies
Figure 8. Human Leukocyte Antigen (HLA) Testing Report Years Considered
Figure 9. Global Human Leukocyte Antigen (HLA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Human Leukocyte Antigen (HLA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Leukocyte Antigen (HLA) Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global Human Leukocyte Antigen (HLA) Testing Market Share by Regions (2022-2027)
Figure 13. Global Human Leukocyte Antigen (HLA) Testing Market Share by Players in 2020
Figure 14. Global Top Human Leukocyte Antigen (HLA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Leukocyte Antigen (HLA) Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Human Leukocyte Antigen (HLA) Testing Revenue in 2020
Figure 16. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Human Leukocyte Antigen (HLA) Testing Market Share by Type (2016-2027)
Figure 20. North America Human Leukocyte Antigen (HLA) Testing Market Share by Application (2016-2027)
Figure 21. North America Human Leukocyte Antigen (HLA) Testing Market Share by Country (2016-2027)
Figure 22. United States Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Human Leukocyte Antigen (HLA) Testing Market Share by Type (2016-2027)
Figure 26. Europe Human Leukocyte Antigen (HLA) Testing Market Share by Application (2016-2027)
Figure 27. Europe Human Leukocyte Antigen (HLA) Testing Market Share by Country (2016-2027)
Figure 28. Germany Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Share by Region (2016-2027)
Figure 38. China Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Human Leukocyte Antigen (HLA) Testing Market Share by Type (2016-2027)
Figure 46. Latin America Human Leukocyte Antigen (HLA) Testing Market Share by Application (2016-2027)
Figure 47. Latin America Human Leukocyte Antigen (HLA) Testing Market Share by Country (2016-2027)
Figure 48. Mexico Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Share by Country (2016-2027)
Figure 54. Turkey Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Human Leukocyte Antigen (HLA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 58. F. Hoffman-La Roche Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 59. Bio-Rad Laboratories Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 60. QIAGEN N.V. Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 61. Illumina Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 62. Immucor Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 63. CareDx Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 64. Becton Dickinson Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 65. Hologic Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 66. GenDx Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 67. Biofortuna Revenue Growth Rate in Human Leukocyte Antigen (HLA) Testing Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---